Lens regeneration in newts occurs exclusively from the dorsal aspect of the iris pigment epithelium. Although the phenomenon has been a paradigm of experimental tissue regeneration, little is understood about how it is initiated and restricted to the dorsal iris. Here we show among various growth factors injected in an intact eye, a single injection of FGF2 specifically caused morphological changes of the iris characteristic of lens regeneration, induced expression of transcription factor genes Pax6, Sox2 and MafB, as well as endogenous Fgf2 in both dorsal and ventral halves, and provoked second lens development only from the dorsal iris. FGF2 protein accumulated in the iris tissue after the lens was removed, and injection of a soluble form of FGF receptor titrating FGF2 inhibited all reactions observed after the lens removal or after administration of FGF2. These results indicate that FGF2 and/or related molecules trigger lens regeneration from the dorsal iris in the newt. The observations also indicate that the absence of lens regeneration from the ventral iris is due to a block in a later phase of lens developmental pathway. q
Introduction
Regeneration of a lost tissue in an animal is an important modern issue, which also has a history of research over a century. Lens regeneration in newts occurring exclusively from the dorsal aspect of the iris pigmented epithelium has been a paradigm of regeneration phenomena. This is referred to as Wolffian lens regeneration after the author of the first academic description of the phenomenon in 1895 (Wolff, 1895) , and a wealth of phenomenological description has been made based on experimental embryology (Mikami, 1941; Reyer, 1954; Yamada, 1966; Eguchi, 1967) .
Many previous works have been carried out on the assumption that the lens regeneration process is initiated only in the dorsal iris (reviewed in Del Rio- Tsonis and Tsonis, 2003) . Other researchers employed various inhibitors which block normal lens development, without much focus on the initiation process (McDevitt et al., 1997; Del Rio-Tsonis et al., 1998) . Thus, no clear view has been provided concerning how the lens regeneration is initiated and dorsal iris specificity is conferred. However, as shown here, a close observation of cellular changes indicates that after the lens is removed, not only the dorsal area but also ventral area of the iris pigmented epithelium proliferates and becomes thickened, implying that the initial response of the tissue is initiated in all areas of the iris, and only later lens development is restricted to the dorsal iris.
We focused on the early initiation process of the lens regeneration in newt eye. We assumed that if the action of a secreted protein factor initiates lens regeneration, administration of the same protein in the normal eye would initiate development of the second lens without removal of the original lens. Involvement of secreted factors in initiation of lens regeneration was suggested by the observation that grafting of a pituitary tissue in an eye chamber initiated development of the second lens (Powell and Segil, 1976) . We demonstrate here that among a number of secreted proteins tested, a single administration of FGF2 specifically initiated development of the second lens in an intact eye. We also provide evidence that FGF2 functions in initiation of the normal regeneration process. Further, either after lens removal or after FGF2 administration, regeneration reactions, namely morphological changes and activation of lens-related transcription factors, occur in all domains of the iris margin, and that the ventral iris tissue fails to complete lens differentiation. These observations do not support the classical theories of lens regeneration, but provide a new insight into how tissue regeneration is regulated.
Results and discussion
2.1. FGF2 specifically induces development of the second lens from the iris If the action of a secreted protein factor initiates lens regeneration, administration of the same protein in normal eye would initiate development of the second lens without lens removal. Among the growth factors tested, (i.e. FGF1, 2, 4, 7, 8, 9, 10, EGF, IGF and VEGF) , FGF2 uniquely Fig. 1 . Second lens development from the dorsal iris after intraocular injection of FGF2. (A) Morphological changes of the iris tissue after injection of FGF2 (50 ng) in an intact eye. Sections were stained with HE (hematoxylin and eosin), for BrdU (red) or for b-crystallin (orange). (B) A scheme of events after intraocular injection of FGF2. After injection of FGF2, the iris cells near the margin begin to proliferate by 8 days, and after 14 days the second lens begins to develop from the dorsal iris. (C) The sequence of events in iris after lens removal, which is very similar to that after FGF2 injection. Arrows in (A) and (C) indicate the second (A) or regenerating (C) lenses. The numbers in parentheses indicate the cases of second lens development or lens regeneration. Bars: 150 mm.
elicited second lens development (Fig. 1A, arrows) . A single injection of FGF2 at 50 ng per eye caused development of the second lens from the dorsal margin of the iris in 92% of the cases (24/26). This effect did not depend on whether the injection was into the anterior or posterior eye chamber (Fig. 2) , and data were mainly collected following injection into the posterior chamber. Injection of 5 ng FGF2 caused second lens development in 1/8 cases (2/16), while 0.5 ng FGF2 had no significant effect.
Morphological changes of iris margins after FGF2 injection or after lens removal were very similar (Fig. 1) . Soon after lens removal or FGF2 administration, cell proliferation occurred in all iris margins (Mikami, 1941; Eisenberg and Yamada, 1966; Eguchi and Shingai, 1971) with its peak after 10 -12 days, as indicated by nuclear incorporation of 5-bromo-2 0 -deoxuridine (BrdU) and increase of the cell mass (Fig. 1A,C) . It was also noted that when the reaction was initiated by removing the lens, cell proliferation was more pronounced in the dorsal margin than the ventral (Fig. 1C) . Cellular melanin content also decreased. A small lens structure with b-crystallin expression was formed in the dorsal margin of the iris after 12 days in the case of FGF2 injection or 14 days after removal of the normal lens (Figs. 1,2) . The lens continued to grow until normal lens size was attained 3 months later (data not shown). When the second lens developed after FGF2 injection, the original lens regressed after 30 days and the second lens eventually replaced the original (Fig. 1A,B) . Interestingly, with FGF2 injection all changes took place 2 days earlier than after lens removal (Figs. 1A,C,2) .
Other FGFs and growth factors were not active in causing any morphological changes or cell proliferation in the iris tissue and did not produce the second lens (Fig. 3 , and data not shown). It was rather unexpected that FGF1 was totally ineffective, in spite of sharing many features with FGF2 and functioning redundantly with FGF2 in many biological processes, e.g. in rat lens development (Lovicu et al., 1997) . We therefore examined phosphorylation of ERK1/2 in the eye tissues injected with FGF1 or FGF2 using immunoblotting of phosphrylated ERK1/2. Phosphorylation of ERK1/2 (p44/p42) MAP kinase is known to be induced by the action of FGF1/2 and essential for fiber differentiation of rat lens cells (Lovicu and McAvoy, 2001) . As shown in Fig. 3D , injection of FGF1 or FGF2 caused a significant increase of ERK1/2 phosphorylation primarily at 44 kDa and secondarily at 42 kDa in the iris and retina tissues, and this increase was comparable after injection of FGF1 and FGF2. This observation confirms that FGF1 recombinant protein employed was active, and suggests an interesting possibility that the initiation of lens regeneration depends on other pathways that distinguish between the action of FGF1 and FGF2.
Initiation of lens regeneration depends on FGF2-related activity
The observations indicated above argue that FGF2 or a related activity is responsible for initiation of lens regeneration from the iris pigmented epithelium. We thus measured FGF2 content in the whole iris tissue before and after lens removal. As shown in Fig. 4A , normal iris contains 2.3^0.3 ng of FGF2 and after lens removal this increased three fold in 6 days (7.3^1.8 ng).
To confirm that FGF2 (or a related activity) is indeed involved in initiation of lens regeneration, we injected soluble recombinant FGF receptors (FGFR2/Fc) that titrate FGFs (Govindarajan and Overbeek, 2001 ). Among FGF receptors, FGFR2(IIIc) form binds FGF1, 2, 4, 9 while FGFR2(IIIb) isoform binds FGF1, 7 and 10 (Ornitz et al., 1996; Powers et al., 2000) . Daily intraocular injection of FGFR2(IIIc)/Fc at 100 ng/eye completely inhibited the reactions leading to lens regeneration, while the isoform FGFR2(IIIb)/Fc was totally ineffective (Fig. 4B) . Injection of 100 ng of FGFR2(IIIc)/Fc, which in stoichiometry binds 25 ng of FGF2 completely blocked lens regeneration, and half inhibition was observed at 10 ng/eye (Fig. 4C) . These results are consistent with the model that activities of FGF2 or related molecules are responsible for the initiation of lens regeneration.
Expression of endogenous Fgf2 and lens development genes after lens removal and FGF2 injection
From morphological criteria and BrdU incorporation, both dorsal and ventral margins of the iris responded to FGF2 administration or lens removal, but only the dorsal margin eventually gave rise to the second lens. To learn about molecular events that take place in the iris tissue and about possible dorso-ventral differences, RNAs were isolated at intervals from iris halves, and analyzed by RT-PCR for expression of Fgf2 and Fgf1, as well as that of transcription factor genes involved in early lens development.
In a previous work using pigmentation-suppressed newt larva and in situ hybridization, Mizuno et al. (1999) showed that Pax6 was activated in both dorsal and ventral iris portions after lens was removed, while Prox1 expression immediately preceding lens differentiation was activated only in the dorsal iris. In normal lens development, combined action of Pax6 and SOX2 initiates lens differentiation (Kamachi et al., 1998; , while SOX2 and a Maf factor cooperate in promoting further lens development (Shimada et al., 2003) , as demonstrated in chicken embryos. SOX1 has a function in later lens fiber development (Kamachi et al., 1998; Nishiguchi et al., 1998) in the chicken and mouse lenses. In the newt lens also, transcription factor genes are expressed in the temporal order consistent with the conserved transcriptional regulation for lens development (Mizuno et al., 1999) . Thus, in addition to Fgf2 and Fgf1 expression of transcription factor genes Pax6, Sox2, MafB (major Maf in newt lens, N. Mizuno, unpublished data), Prox1 and Sox1, as well as the earliest lens protein gene bB1-crystallin was investigated (Fig. 5) .
Endogenous Fgf2 expression in the iris increased after lens removal or FGF2 injection (Fig. 5A ). This increase was more pronounced in the dorsal half of the iris than the ventral half in the lens-removed sample, but in FGF2-injected eyes the increase was comparable between dorsal and ventral halves. These observations argue that Fgf2 expression is activated by a paracrine mechanism, and dorso-ventral difference of Fgf2 expression after lens removal may indicate that the initial supply of FGF2 is higher in the dorsal half, while intraocular injection which distributed FGF2 broadly in the eye triggered endogenous Fgf2 expression in the iris equally between the two halves. By contrast, expression of Fgf1, which took place at a low level in the iris tissue, was not affected either by lens removal or by FGF2 injection, supporting the view that FGF1 is not involved in the early regeneration process of the newt lens.
Pax6 transcripts of two different sizes generated by alternative RNA splicing (Mizuno et al., 1997) were already present in normal iris and increased significantly in both dorsal and ventral halves (Fig. 5B) , confirming the previous observation on larval iris using in situ hybridization (Mizuno et al., 1999) . It was noted that the increase of Pax6 transcripts was more pronounced in the dorsal halves, regardless of whether it was initiated by lens removal or by FGF2 administration. However, the level of Pax6 transcripts was not correlated with whether development of the second lens really took place. For instance, Pax6 levels in the iris ventral halves after FGF2 administration were comparable to those of dorsal halves after lens removal.
In normal iris Sox2 is expressed at a very low level, while MafB transcript is undetectable, but their expression was activated in both halves of iris either after lens removal or FGF2 administration (Fig. 5B) . Their expression levels were augmented further in the dorsal halves when the second lenses had already been formed (Fig. 5B , in the areas in orange rectangles). In the irises of lens-removed eyes, the expression levels of Sox2 and MafB transcripts were higher in the dorsal halves, but they were equally high in both halves in FGF2-injected eyes (Fig. 5B) .
Prox1 transcripts were detected only in the dorsal iris halves under the conditions where the second lenses were formed (Fig. 5C) , consistent with the observation in larval iris (Mizuno et al., 1999) . Expression of bB1-crystallin and Sox1 was also detectable when the second lenses were formed (Fig. 5C ).
The steps and regulation of lens regeneration
We have provided evidence that FGF2 acts as the agent to trigger lens regeneration (as shown by development of the second lens): (1) A single injection of FGF2 to an intact eye initiates development of the second lens, but none of FGF1, 4, 7, 8, 9 , 10 or other growth factors does so (Figs. 1A,3) ; (2) Either removal of the lens or and FGF2 administration activates endogenous Fgf2 expression (Fig. 5A ) and elicits the analogous sequence of events leading to second lens development (Figs. 1,2) ; (3) Lens removal causes accumulation of FGF2 protein in the iris (Fig. 4A) ; and (4) Titration of intraocular FGFs by FGFR2(IIIc)/Fc inhibits all reactions of the iris tissue that occur after removal of the lens (Fig. 4B,  C ). All these observations indicate that FGF2 is the molecule which initiates lens regeneration in newt iris, although possible participation of analogous secreted factors acting in parallel with FGF2 is not excluded. The question of what the first source of FGF2 is to act on iris after lens removal remains to be investigated. The activity of FGF2 in lens regeneration distinct from FGF1 also leaves the identity of FGF2 receptor in this reaction as an open question, since it is generally considered that signaling by these FGF proteins are conveyed through common receptors (e.g. Lovicu et al., 1997; Lovicu and Overbeek, 1998) .
Involvement of FGF-related activities in the maturation of the normal lens has been indicated (McAvoy and Chamberlain, 1989; Lovicu and Overbeek, 1998) , and analogous observation has been made on regenerating lens (Hayashi et al., 2002 and references therein). FGF2 action described in this present work, on the other hand, deals with the earlier initiation process of lens regeneration.
An important observation was that both dorsal and ventral halves of the iris responded to lens removal or FGF2 administration, in initial morphological changes and in activation of Fgf2, Pax6, Sox2 and MafB genes. After lens removal, these responses were larger in the dorsal half, which may imply a dorsally localized FGF2 source, or reflect an uneven distribution of FGF receptors or other reactions in the iris as suggested previously (McDevitt et al., 1997; Del Rio-Tsonis et al., 1997; Imokawa and Brockes, 2003) . In a previous work reported by Eguchi and Shingai (1971) , two waves of DNA synthesis was noted in the iris after lens removal, first dominantly in the dorsal portion and second in the wide area. We speculate that the first wave reflect the response to the dorsally localized initial FGF2 action, and the second wave to the endogenously synthesized FGF2 which was demonstrated to occur in Fig. 5A .
However, this differential response between the dorsal and ventral halves of the iris after lens removal cannot be the major cause limiting lens regeneration only from the dorsal margin of the iris, since single administration of FGF2 to an eye chamber initiated the first responses for lens development very similarly in both dorsal and ventral halves (Figs. 1, 5) .
Thus, in the subsequent steps either the dorsal compartment of the iris contains additional factors required for lens development or the ventral compartment has a mechanism to inhibit lens development. In support of the latter mechanism, there is a report that treatment with a chemical (N-methyl-N 0 -nitro-N-nitrosoguanidine) following lens removal caused development of multiple lenses also from the ventral iris (Eguchi and Watanabe, 1973) . In either case, limitation of the dorsal iris as the site of lens regeneration will be the mechanism by which only a single new lens is produced in regeneration.
Lens regeneration from the dorsal side of the iris has served as a paradigm of tissue regeneration. The major issues have been what initiates regeneration reactions and how the dorsal iris is selected as the source of the regenerating lens. We have demonstrated that FGF2 initiates lens regeneration reactions in all domains of the iris margin including expression of transcription factors for early lens development, but that the ventral iris tissue fails to complete lens differentiation. Thus, the central problems of this century's mystery have been largely answered.
Experimental procedures

Microinjection into eye chambers of newt
Adult Japanese newts (Cynops pyrrhogaster) were obtained from Hamamatsu Experimental Animals, and used for operations under anesthesia with 0.1% MS222 (Sigma). Recombinant growth factors (human origin, except for mouse FGF8b) were from Sigma, and FGFR2(IIIc)/Fc and FGFR2(IIIb)/Fc from R&D. These proteins were dissolved in Hanks' saline of 80% strength optimized for use in newts (Okamoto et al., 1998) , and injected into the anterior eye chamber through the cornea, or into the posterior chamber through the sclera using a fine glass pipette. Lentectomy was done first by making a horizontal incision through the cornea and by pulling out the whole lens with forceps through the incision.
Labeling proliferating iris cells with BrdU
The newts were injected with 1 mg/g body weight of BrdU in the abdominal cavity. Tissues were excised after 48 h, fixed, sections made in paraffin, deparaffinized and immunochemically stained using anti-BrdU mouse antibody (monoclonal, Roche), alkaline phosphatase (AP)-linked anti-mouse antibodies, and Fast Red TR/Naphthol AS-MX system (sigma). The right eye of a new was injected with FGF1 or FGF2 at 50 ng and left eye with PBS. After 24 h, iris and retina tissues were collected from five eyes, and were sonicated for 1 min in 200 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% sodium dodecylsulphate (SDS)). Forty microliters of the lysates were electrophoresed in SDS -15% polyacrylamide gel, blotted onto a nitrocellulose membrane (Schleicher and Schuell), and processed for immunoblotting using antibodies which specifically recognize phosphorylated ERK1/2 epitope (Cell Signaling Technology) and AP-linked secondary antibodies and NBT/BCIP. The anti-phosphorylated ERK1/2 antibodies were raised against the phylogenically conserved epitope and recognize newt ERK1/2 (p44 and p42).
Detection of FGF in the iris tissue
Anti-newt FGF2 antibodies were raised in rabbit by injecting recombinant newt FGF2 -GST fusion proteins that were expressed in E. coli and purified using glutathione column. The antiserum did not react with newt FGF1 protein. The whole iris tissue excised from a lens-removed newt eye was sonicated in 40 ml of lysis buffer, and the lysate was electrophoresed, blotted and processed for immunoblotting using anti-newt FGF2 antibodies using the same procedure as described above. FGF content was estimated using Image Analyzer LAS-1000 Plus (Fuji photo film) with Image Gauge Ver. 3.4 software (Fuji photo film), and using purified recombinant newt FGF2 as standard.
Immunohistology of b-crystallins
Mouse monoclonal antibody specific to b-class crystallins (Sawada et al., 1993) was provided by Riken Cell Bank. Histological sections treated with this antibody were processed for orange color development with peroxidase-linked secondary antibodies and chromogenic aminoethylcarbazole.
RT-PCR analysis
Total RNA was extracted from eye tissues derived from 12 eyeballs using TRIzol (Invitrogen). cDNAs were synthesized by Superscript III enzyme (Invitrogen) using random primers and 100 ng total RNA as template, and sequences for Fgf2 (accession no. AB064664), Fgf1 (AB175665), Pax6 (D88741), Sox2 (AB154819), MafB (AB154825), Prox1 (AB008774), Sox1 (AB154820) and bB1-crystallin (D86300) were further amplified by PCR using following sets of primers (forward vs. 0 , 5 0 -GATCCCCGTCAGGGTAAG-3 0 ) and bB1-crystallin (5 0 -GGATACCTGGTCTAACAG-3 0 , 5 0 -GCCACTGCATGTCCCTG-3 0 ). The PCR products were electrophoresed and stained with SYBR GREEN I (Molecular Probes).
